Literature DB >> 28862199

An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis.

Samiha Bari1, Rashmi Metgud1, Zankhana Vyas1, Aniruddh Tak1.   

Abstract

Worldwide estimates of oral submucous fibrosis (OSMF) show a confinement to Indians and Southeast Asians. In India, the prevalence of OSMF has increased over the past four decades from 0.03% to 6.42%. The condition is well recognized for its malignant potential rate of 7-30%. The condition has a multifactorial etiology and may remain either stationary or become severe, leaving an individual physically challenged both physically and psychologically. Hence, the study aims at reviewing studies done on various etiological factors leading to its onset. Their analysis may serve as an adjunct in defining the broad spectrum of the causation of this potentially malignant disorder.

Entities:  

Mesh:

Year:  2017        PMID: 28862199     DOI: 10.4103/0973-1482.179524

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  12 in total

1.  Comparative Evaluation of Reconstructive Methods in Oral Submucous Fibrosis.

Authors:  B C Sikkerimath; Satyajit Dandagi; Aditya Anshu; Anu Jose
Journal:  J Maxillofac Oral Surg       Date:  2021-01-23

2.  A novel approach to develop an animal model for oral submucous fibrosis.

Authors:  Madhura Shekatkar; Supriya Kheur; Avinash Sanap; Vaishali Undale; Avinash Kharat; Vrushali Bhalchim; Arati Dubewar; Ramesh Bhonde
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

3.  Evaluation of the Efficacy of Loricrin as a Diagnostic Marker in Patients with Oral Submucous Fibrosis.

Authors:  Niva Mahapatra; Kailash C Dash; Lipsa Bhuyan; Abikshyeet Panda; Shyam S Behura; Pallavi Mishra
Journal:  J Pharm Bioallied Sci       Date:  2020-08-28

4.  No age predilection for a disease like OSMF. A case report of 5-year-old child.

Authors:  Pratik Kariya; Vishal Khobragade; Shraddha Sura; Sweta Singh
Journal:  J Oral Biol Craniofac Res       Date:  2020-04-10

5.  Expression of p63 and Proliferating Cell Nuclear Antigen in Oral Submucous Fibrosis.

Authors:  S Suwasini; Manisha Shrikaar; Nishu Kumari; Abhishek Singh; Khusboo Kumari; Madhuresh Kumar
Journal:  J Int Soc Prev Community Dent       Date:  2021-07-30

6.  Correlation of Clinical Features in Oral Submucous Fibrosis: A 9-Year Retrospective Study.

Authors:  Sneha R Sharma; Samiksha Chavan; Freny R Karjodkar; Kaustubh Sansare; S Bharathi; Shivani Singh
Journal:  Ethiop J Health Sci       Date:  2022-01

7.  Buccal Mucosal Epithelial Cells Downregulate CTGF Expression in Buccal Submucosal Fibrosis Fibroblasts.

Authors:  Sanjay Gottipamula; Sudarson Sundarrajan; Aditya Moorthy; Sriram Padmanabhan; K N Sridhar
Journal:  J Maxillofac Oral Surg       Date:  2017-11-17

8.  Adipose-Derived Stem Cell-Derived Extracellular Vesicles Inhibit the Fibrosis of Fibrotic Buccal Mucosal Fibroblasts via the MicroRNA-375/FOXF1 Axis.

Authors:  Bin Han; Yanhui Zhang; Yuxia Xiao; Bohong Shi; Hong Wu; Desheng Liu
Journal:  Stem Cells Int       Date:  2021-06-22       Impact factor: 5.443

9.  Network-based identification of signature genes KLF6 and SPOCK1 associated with oral submucous fibrosis.

Authors:  Prithvi Singh; Arpita Rai; Ravins Dohare; Shweta Arora; Sher Ali; Shama Parveen; Mansoor Ali Syed
Journal:  Mol Clin Oncol       Date:  2020-01-30

Review 10.  Oral Submucous Fibrosis: A Review on Biomarkers, Pathogenic Mechanisms, and Treatments.

Authors:  Yen-Wen Shen; Yin-Hwa Shih; Lih-Jyh Fuh; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.